Yüklüyor......

Osimertinib or EGFR-TKIs/chemotherapy in patients with EGFR-mutated advanced nonsmall cell lung cancer: A meta-analysis

BACKGROUND: The aim of this meta-analysis is to investigate the impact of Osimertinib on treatment efficacy in advanced nonsmall cell lung cancer (NSCLC). METHODS: Trials comparing Osimertinib against epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)/chemotherapy in patients wi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Huang, Lei, Huang, Hao, Zhou, Xiao-Ping, Liu, Jin-Feng, Li, Chun-Rong, Fang, Min, Wu, Jun-Rong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6824777/
https://ncbi.nlm.nih.gov/pubmed/31651902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017705
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!